Oncology 5 Flashcards
What do all lymphomas have in common?
They originate from lymphoreticular.
Multicentric (nodal) lymphoma…
1. Examples of clinical signs.
2. Approx. frequency in dogs.
3. Approx. frequency in cats.
- Painless lymphadenopathy, PUPD (hypercalcaemia), other non-specific signs.
- 80%.
- 20-30%.
Alimentary lymphoma…
1. Examples of clinical signs.
2. Approx. frequency in dogs.
3. Approx. frequency in cats.
- Vomiting, weight loss, diarrhoea, maybe palpably thickened intestinal loops and palpable abdominal mass.
- 7%.
- 50-70%.
Cutaneous lymphoma…
1. Examples of clinical signs.
2. Approx. frequency in dogs.
3. Approx. frequency in cats.
- Wide variety of non-specific changes – generalised or solitary. May progress from scaly alopecia to thickened erythematous ulcerative lesions. May or may not be pruritic.
- 6%.
- 0.2-3%.
Mediastinal lymphoma…
1. Examples of clinical signs.
2. Approx. frequency in dogs.
3. Approx. frequency in cats.
- Dyspnoea, tachypnoea (from space-occupying effect and/or pleural effusion), pre-caval syndrome +/- PUPD.
- 3%.
- 10-20%.
Extra-nodal e.g. bone, nasal, CNS…
1. Examples of clinical signs.
2. Approx. frequency in dogs.
3. Approx. frequency in cats.
- Site-dependent.
- 3%.
- 1-10%.
Diagnosing lymphoma.
- FNA of enlarged LNs of affected organs for cytology is frequently rewarding – avoid submandibular where possible (more likely to see a mixed picture).
- ## Biopsy if FNA non-diagnostic.
Further staging of lymphoma.
- Tailored to individual and circumstances.
- Aids decisions regarding chemotherapy.
- For prognosis: -
– Haematology.
– Biochemistry.
– Thoracic radiographs –> mediastinal mass negative prognostic factor.
– Abdominal US –> Stage III and IV = same outcome.
– FNA +/- tissue biopsy.
– immunophenotyping (immunocyto. / histochemisty).
– Bone marrow aspirate if haematological abnormalities.
WHO staging system for lymphoma.
- Firstly, anatomical site.
- Then stage:-
– I = involving single node or lymphoid tissue in single organ.
– II = involvement of multiple LNs in a region.
– III = generalised lymphadenopathy.
– IV = III plus liver/spleen involvement.
– V = blood / bone marrow involvement. - Then substage: -
– a = clinically well (w/o systemic signs).
– b = clinically unwell (w/ systemic signs).
- How do you classify lymphoma grade?
- How else can lymphoma be classified?
- small/large cell OR high/intermediate/low.
- By immunophenotype. i.e. B cell or T cell.
Classifications w/ worse prognosis.
T cell lymphomas.
Large cell type.
Higher stages.
Substage b.
Male.
Presence of hypercalcaemia.
Forms that are not multicentric.
Pre-treatment w/ steroids.
Classifications w/ better prognosis.
B cell.
Small cell type.
Lower stages.
Substage a.
Being female.
Absence of hypercalcaemia.
Multicentric form.
Avoidance of steroid pre-treatment.
CHOP protocol for lymphoma treatment.
Median survival time = 12 months.
75-90%.
25%.
COP protocol for treatment of lymphoma.
Median survival time = 6-9 months.
70-80% remission.
Single agent doxorubicin every 3 weeks protocol for lymphoma treatment.
Median survival time = 6-9 months.
Single agent prednisolone protocol for lymphoma treatment.
Median survival time = 2-3 months.
MST if no treatment.
4-6wks.
What drugs are used in CHOP protocol?
Cyclophosphamide.
Hydroxydaunorubicin (doxorubicin).
Oncovin (vincristine).
Prednisolone.
What drugs are used in COP protocol for lymphoma treatment?
Cyclophosphamide.
Oncovin (vincristine).
Prednisolone.
- ‘Positives’ to cat lymphoma.
- Negatives of cat lymphoma.
- Solitary disease more common than in dogs so surgical treatment and/or radiotherapy possible in these cases.
– Nasal lymphoma can go into prolonged remission.
– Old cats w/ ‘small cell’ alimentary lymphoma can have remission periods of 2yrs w/ ust oral prednisolone and chlorambucil. - – More likely to be substage b.
– Chemotherapy challenging due to their small size.
– Cats do not tolerate doxorubicin well.
– Generally respond less well to treatment.
– COP protocol MST = 8m and remission rates only 50-70%.
– ~30% achieve longer-lasting complete remission of >1.5yrs.
- What can resistance to lymphoma treatments be caused by?
- When is euthanasia appropriate?
- Insufficient dosing.
Failure to achieve therapeutic concentration at ‘sanctuary sites’. e.g. CNS.
Multi-drug resistance (MDP-1 gene expression).
– expression of p-glycoprotein transmembrane drug efflux pump.
– induced by pre-treatment w/ steroids. - When QoL is inadequate.
- What is leukaemia?
- 2 leukaemia subdivisions.
- Neoplastic proliferation of haemopoietic cells originating from within the bone marrow.
- Lymphoid i.e. originating from lineages of lymphocytic cells e.g. common lymphoid progenitor, NK cells, lymphocytes, plasma cells.
- Non-lymphoid (aka myeloid) e.g. originating from neutrophil, basophil, eosinophil, monocyte, megakaryocyte, mast cell and erythrocyte cell lineages.
- Lymphoid i.e. originating from lineages of lymphocytic cells e.g. common lymphoid progenitor, NK cells, lymphocytes, plasma cells.
How else can we classify leukaemia?
- Acute – poorly differentiated, generally rapid disease course.
- Chronic – well differentiated, generally insidious diseases.
Clinical signs and general features of leukaemia.
- Infiltration of neoplastic cells into bone marrow impedes production of normal haemopoietic cells.
– can cause variable degrees of ‘penias’ as seen upon haematology e.g.: -
–> Anaemia –> usually non-regenerative.
–> Thrombocytopenia.
–> Neutropenia. - High numbers of circulating neoplastic cells are usually seen (e.g. lymphocytosis) due to circulating neoplastic ‘lymphoblasts’.
- Infiltration of liver and spleen generally common.